# Mirum Pharmaceuticals, Inc.: Form 8-K, filed May 4, 2026

- Company: [Mirum Pharmaceuticals, Inc.](/companies/mirm.md) (CIK 1759425)
- Form: 8-K
- Filed: 2026-05-04
- Accepted by EDGAR: May 4, 2026, 08:00 ET
- Period: 2026-05-04
- Accession: 0001193125-26-202609
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1759425/000119312526202609/d150234d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1759425/000119312526202609/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1759425/000119312526202609/d150234d8k.htm

Filed May 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-202609. Last ingested by Listed: Nov 12, 2026, 18:24 ET. No prices; not investment advice.